Occurrence and in-stream attenuation of wastewater-derived pharmaceuticals in Iberian rivers
dc.contributor.author
dc.date.accessioned
2016-04-29T09:56:35Z
dc.date.available
2017-01-16T04:00:06Z
dc.date.issued
2015-01-15
dc.identifier.issn
0048-9697
dc.identifier.uri
dc.description.abstract
Amultitude of pharmaceuticals enter surface waters via discharges of wastewater treatment plants (WWTPs), and
many raise environmental and health concerns. Chemical fate models predict their concentrations using estimates
of mass loading, dilution and in-stream attenuation. However, current comprehension of the attenuation rates remains
a limiting factor for predictive models.We assessed in-stream attenuation of 75 pharmaceuticals in 4 river
segments, aiming to characterize in-stream attenuation variability among different pharmaceutical compounds,
as well as among river segments differing in environmental conditions. Our study revealed that in-streamattenuation
was highly variable among pharmaceuticals and river segments and that none of the considered pharmaceutical
physicochemical and molecular properties proved to be relevant in determining the mean attenuation rates.
Instead, the octanol–water partition coefficient (Kow) influenced the variability of rates among river segments, likely
due to its effect on sorption to sediments and suspended particles, and therefore influencing the balance between
the different attenuation mechanisms (biotransformation, photolysis, sorption, and volatilization). The magnitude
of themeasured attenuation rates urges scientists to consider themas important as dilutionwhen aiming to predict
concentrations in freshwater ecosystems
dc.description.sponsorship
This research was supported by aMarie Curie European Reintegration Grant (PERG07-GA-2010-259219) and by a Marie Curie Career Integration Grant (PCIG9-GA-2011-293535) within the 7th European Community Framework Programme, aswell as by the SpanishMinistry of Economy and Competitiveness through the projects SCARCE (Consolider-Ingenio 2010 CSD2009-00065) and ENDERUS (CTM-2009-13018), and the postdoctoral grants “Juan de la Cierva” (jci-2009-05604 and jci-2010- 06397), and by the European Union through the European Regional Development Fund (FEDER). This work was partly supported by the Generalitat de Catalunya (Consolidated Research Group: Water and Soil Quality Unit 2009-SGR-965)
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier
dc.relation
info:eu-repo/grantAgreement/MICINN//CSD2009-00065/ES/Evaluación y predicción de los efectos del cambio global en la cantidad y la calidad del agua en ríos ibéricos/
AGAUR/2009-2014/2009 SGR-965
dc.relation.isformatof
Versió postprint del document publicat a: https://doi.org/10.1016/j.scitotenv.2014.05.067
dc.relation.ispartof
© Science of the Total Environment, 2015, vol. 503-504, p. 133-141
dc.relation.ispartofseries
Articles publicats (D-EQATA)
dc.rights
Reconeixement-NoComercial-SenseObraDerivada 4.0 Internacional
dc.rights.uri
dc.subject
dc.title
Occurrence and in-stream attenuation of wastewater-derived pharmaceuticals in Iberian rivers
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.relation.projectID
info:eu-repo/grantAgreement/EC/FP7/259219/EU/Global warming effects on the stream carbon balance/GWESCB
info:eu-repo/grantAgreement/EC/FP7/293535/EU/Ecosystem-based management strategies for urban wastewater systems/ECOMAWAT
dc.type.version
info:eu-repo/semantics/acceptedVersion
dc.identifier.doi
dc.identifier.idgrec
023500
dc.contributor.funder
dc.relation.ProjectAcronym